Showing results (101-110 of 112) with videos related to
Sort By:
Pageof 12
Nature Medicine|August 21, 2007
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapyLionel Apetoh, François Ghiringhelli, Antoine Tesniere, et al.Cancers|July 2, 2021
5' Region Large Genomic Rearrangements in the <i>BRCA1</i> Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent BreakpointsSandrine M Caputo, Dominique Telly, Adrien Briaux, et al.Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.Human Mutation|April 17, 2012
Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variantsClaude Houdayer, Virginie Caux-Moncoutier, Sophie Krieger, et al.International Journal of Cancer|May 19, 2005
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 geneDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutationsSophie M Ginolhac, Sophie Gad, Marilys Corbex, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriersDavid J Hughes, Sophie M Ginolhac, Isabelle Coupier, et al.Journal of Medical Genetics|August 15, 2012
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer riskAmanda B Spurdle, Phillip J Whiley, Bryony Thompson, et al.Breast Cancer Research and Treatment|July 24, 2010
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutationAna Peixoto, Catarina Santos, Manuela Pinheiro, et al.Nature|October 21, 2011
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinomaCorine Bertolotto, Fabienne Lesueur, Sandy Giuliano, et al.Pageof 12